TTI-101
202602103
Phase 1 small_molecule active
Quick answer
TTI-101 for Pancreatic Cancer is a Phase 1 program (small_molecule) at Tvardi Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tvardi Therapeutics
- Indication
- Pancreatic Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active